| Pharmaceutical Information |
| Drug Name |
Anti-thymocyte globulin (rabbit) |
| Drug ID |
BADD_D00146 |
| Description |
Rabbit anti-thymocyte globulin. Thymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients. Thymoglobulin is a mixture of antibodies intended to bind to various cell surface antigens. The most common mode of action of Thymoglobulin is via selective depletion of T-cells. |
| Indications and Usage |
For prevention of renal transplant rejection |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB00098
|
| KEGG ID |
Not Available
|
| MeSH ID |
C512542
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
58468-0080 |
| UNII |
Not Available
|
| Synonyms |
thymoglobulin | anti-thymocyte globulin (rabbit) | rabbit ATG | rabbit antithymocyte globulin | rabbit anti-human thymocyte globulin | lapine T-lymphocyte immune globuin | antithymocyte immunoglobulin |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
308067-60-9 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
